News and Events

Press Releases

July 28, 2021
Venatorx Pharmaceuticals Announces Positive Phase 1 Results for VNRX-7145
July 15, 2021
Venatorx Pharmaceuticals Named 'Best Places to Work' Fourth Year in a Row
June 29, 2021
Venatorx Pharmaceuticals Names Mary Beth Dorr, Ph.D. Vice President, Clinical Science
>> More Press Releases

In the News

July 23, 2021
Burns & Mahadevia: Pasteur Act can reinvigorate broken antibiotic market
June 23, 2021
Combating antimicrobial resistance
May 03, 2021
Venatorx Pharmaceuticals is the 'Company to Watch'
>> More News
You are using a browser that is not supported. Please consider changing your browser